| __timestamp | Amgen Inc. | Arrowhead Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4699000000 | 24419536 |
| Thursday, January 1, 2015 | 4846000000 | 34718089 |
| Friday, January 1, 2016 | 5062000000 | 40998209 |
| Sunday, January 1, 2017 | 4870000000 | 32022880 |
| Monday, January 1, 2018 | 5332000000 | 19110051 |
| Tuesday, January 1, 2019 | 5150000000 | 26556257 |
| Wednesday, January 1, 2020 | 5730000000 | 52275890 |
| Friday, January 1, 2021 | 5368000000 | 80981000 |
| Saturday, January 1, 2022 | 5414000000 | 124431000 |
| Sunday, January 1, 2023 | 6179000000 | 90932000 |
| Monday, January 1, 2024 | 98761000 |
Unleashing the power of data
In the competitive landscape of the pharmaceutical industry, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Over the past decade, Amgen Inc. and Arrowhead Pharmaceuticals, Inc. have demonstrated contrasting approaches to SG&A cost management.
From 2014 to 2023, Amgen's SG&A expenses have shown a steady increase, peaking at approximately $6.2 billion in 2023, reflecting a 31% rise from 2014. In contrast, Arrowhead Pharmaceuticals, Inc. has maintained a more conservative approach, with expenses growing from $24 million in 2014 to $91 million in 2023, marking a significant increase but still a fraction of Amgen's costs.
This disparity highlights Amgen's expansive operational scale compared to Arrowhead's more focused strategy. As the industry evolves, these companies' ability to manage SG&A costs effectively will be pivotal in sustaining their competitive edge.
Who Optimizes SG&A Costs Better? Amgen Inc. or Walgreens Boots Alliance, Inc.
Comparing SG&A Expenses: Amgen Inc. vs TG Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: Amgen Inc. vs Merus N.V.
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Soleno Therapeutics, Inc.
Comparing SG&A Expenses: Genmab A/S vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Operational Costs Compared: SG&A Analysis of Halozyme Therapeutics, Inc. and Arrowhead Pharmaceuticals, Inc.
Comparing SG&A Expenses: Alkermes plc vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Breaking Down SG&A Expenses: Ultragenyx Pharmaceutical Inc. vs Arrowhead Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Arrowhead Pharmaceuticals, Inc. and Mesoblast Limited
Arrowhead Pharmaceuticals, Inc. and Geron Corporation: SG&A Spending Patterns Compared
Arrowhead Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Arrowhead Pharmaceuticals, Inc. and Evotec SE